BEXAGLIFLOZIN

BEXAGLIFLOZIN was reported 31 times

These side effects are most commonly reported by patients taking BEXAGLIFLOZIN:

# Side effect Count
0 HEADACHE 7
1 WEIGHT DECREASED 7
2 FATIGUE 6
3 NAUSEA 6
4 COUGH 5
5 DECREASED APPETITE 5
6 ASTHENIA 4
7 CHEST DISCOMFORT 4
8 DYSPNOEA 4
9 GASTROINTESTINAL DISORDER 4
10 OROPHARYNGEAL PAIN 4
11 THROAT IRRITATION 4
12 THROAT TIGHTNESS 4
13 ABDOMINAL PAIN UPPER 3
14 BLOOD GLUCOSE INCREASED 3
15 DIARRHOEA 3
16 DIZZINESS 3
17 DYSPNOEA EXERTIONAL 3
18 HOT FLUSH 3
19 MUSCLE SPASMS 3
20 OXYGEN SATURATION DECREASED 3
21 ABDOMINAL DISCOMFORT 2
22 DRUG INEFFECTIVE 2
23 DYSPEPSIA 2
24 GASTROOESOPHAGEAL REFLUX DISEASE 2
25 HERNIA 2
26 PRODUCT DOSE OMISSION ISSUE 2
27 PRODUCT USE IN UNAPPROVED INDICATION 2
28 PRODUCTIVE COUGH 2
29 PRURITUS 2
30 THERAPY INTERRUPTED 2
31 ABDOMINAL DISTENSION 1
32 ABDOMINAL HERNIA REPAIR 1
33 ACCIDENTAL UNDERDOSE 1
34 ACNE 1
35 ACUTE KIDNEY INJURY 1
36 ADENOCARCINOMA 1
37 ALBUMINURIA 1
38 ALOPECIA 1
39 ANAEMIA 1
40 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 1
41 BACK PAIN 1
42 BLISTER 1
43 BLOOD CALCIUM DECREASED 1
44 BRAIN FOG 1
45 BRONCHITIS 1
46 CHROMATURIA 1
47 CHRONIC KIDNEY DISEASE 1
48 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1
49 CONDITION AGGRAVATED 1
50 COVID-19 1
51 CYTOKINE RELEASE SYNDROME 1
52 DEVICE DELIVERY SYSTEM ISSUE 1
53 DEVICE DIFFICULT TO USE 1
54 DISEASE PROGRESSION 1
55 DRUG DOSE OMISSION BY DEVICE 1
56 DRY SKIN 1
57 ELECTROLYTE IMBALANCE 1
58 EMPHYSEMA 1
59 ENERGY INCREASED 1
60 ERYTHEMA 1
61 FACIAL PAIN 1
62 FALL 1
63 FALLOPIAN TUBE CANCER STAGE III 1
64 GAIT INABILITY 1
65 GLYCOSURIA 1
66 GLYCOSYLATED HAEMOGLOBIN INCREASED 1
67 HAIR GROWTH ABNORMAL 1
68 HIATUS HERNIA 1
69 HYPERGLYCAEMIA 1
70 HYPERHIDROSIS 1
71 ILLNESS 1
72 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1
73 IMPAIRED GASTRIC EMPTYING 1
74 INCORRECT DOSE ADMINISTERED 1
75 INCREASED APPETITE 1
76 INSOMNIA 1
77 INSURANCE ISSUE 1
78 INTENTIONAL DOSE OMISSION 1
79 IRON DEFICIENCY ANAEMIA 1
80 IRRITABILITY 1
81 JOINT STIFFNESS 1
82 LETHARGY 1
83 LIQUID PRODUCT PHYSICAL ISSUE 1
84 LYMPHOEDEMA 1
85 MALAISE 1
86 MOTION SICKNESS 1
87 MYECTOMY 1
88 NASOPHARYNGITIS 1
89 NEPHROGENIC ANAEMIA 1
90 NERVE COMPRESSION 1
91 NO ADVERSE EVENT 1
92 NOCTURIA 1
93 OCULAR HYPERAEMIA 1
94 OEDEMA PERIPHERAL 1
95 OESOPHAGOGASTRIC FUNDOPLASTY 1
96 PAIN 1
97 PALLOR 1
98 PATIENT DISSATISFACTION WITH TREATMENT 1
99 PENILE SIZE REDUCED 1
100 PERIPHERAL COLDNESS 1
101 POST PROCEDURAL COMPLICATION 1
102 PRODUCT ADMINISTRATION ERROR 1
103 PRODUCT COLOUR ISSUE 1
104 PRODUCT DOSE OMISSION IN ERROR 1
105 PRODUCT USE ISSUE 1
106 PROTEINURIA 1
107 PSORIASIS 1
108 PSORIATIC ARTHROPATHY 1
109 PSYCHOMOTOR HYPERACTIVITY 1
110 RENAL PAIN 1
111 RENAL TRANSPLANT 1
112 SECRETION DISCHARGE 1
113 SEPSIS 1
114 SKIN WARM 1
115 SLEEP DISORDER 1
116 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
117 THERAPEUTIC RESPONSE DECREASED 1
118 THIRST 1
119 TRICUSPID VALVE INCOMPETENCE 1
120 UPPER RESPIRATORY TRACT INFECTION 1
121 URINARY TRACT INFECTION 1
122 VERTIGO 1
123 VIRAL INFECTION 1
124 VITAMIN D DEFICIENCY 1
125 VOMITING PROJECTILE 1
126 WEIGHT GAIN POOR 1
127 WEIGHT INCREASED 1
128 WEIGHT LOSS POOR 1
129 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1
130 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1